Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer. - Wikidata - wikimedia - TriplyDB

Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer.

Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer.

http://www.wikidata.org/entity/Q37689601

about

Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy Common stemness regulators of embryonic and cancer stem cells Tumor and stromal-based contributions to head and neck squamous cell carcinoma invasion Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells.Targeting Head and Neck Cancer Stem Cells: Current Advances and Future Challenges CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma.The war on cancer: lessons from the war on terror SMURF1 silencing diminishes a CD44-high cancer stem cell-like population in head and neck squamous cell carcinoma.Sensitizing ovarian cancer cells to chemotherapy by interfering with pathways that are involved in the formation of cancer stem cells.Anti-tumor effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma.A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.miR-203 inhibits proliferation and self-renewal of leukemia stem cells by targeting survivin and Bmi-1.STAT3 blockade enhances the efficacy of conventional chemotherapeutic agents by eradicating head neck stemloid cancer cell.Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice.NOTCH1 inhibition enhances the efficacy of conventional chemotherapeutic agents by targeting head neck cancer stem cell.Sulforaphane improves chemotherapy efficacy by targeting cancer stem cell-like properties via the miR-124/IL-6R/STAT3 axis.Histone modifications: Targeting head and neck cancer stem cells.Non-genetic cancer cell plasticity and therapy-induced stemness in tumour relapse: 'What does not kill me strengthens me'.Enhanced SLC34A2 in breast cancer stem cell-like cells induces chemotherapeutic resistance to doxorubicin via SLC34A2-Bmi1-ABCC5 signaling.Modeling head and neck cancer stem cell-mediated tumorigenesis.Myrtucommulone-A treatment decreases pluripotency- and multipotency-associated marker expression in bladder cancer cell line HTB-9.Thyroid cancer surgery guidelines in an era of de-escalation.Cancer Stem Cells in Oral Cavity Squamous Cell Carcinoma: A Review.Current understanding of cancer stem cells: Review of their radiobiology and role in head and neck cancers.Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy Therapeutic Inhibition of the MDM2-p53 Interaction Prevents Recurrence of Adenoid Cystic Carcinomas.IL-6 Inhibition With MEDI5117 Decreases The Fraction of Head and Neck Cancer Stem Cells and Prevents Tumor Recurrence.Polycomb genes are associated with response to imatinib in chronic myeloid leukemia.Isolation and Characterization of Cancer Stem Cells from Primary Head and Neck Squamous Cell Carcinoma Tumors.Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLC Bufalin reverses acquired drug resistance by inhibiting stemness in colorectal cancer cells.Novel C-Terminal Heat Shock Protein 90 Inhibitors (KU711 and Ku757) Are Effective in Targeting Head and Neck Squamous Cell Carcinoma Cancer Stem cells.Pharmacological inhibition of Bmi1 by PTC-209 impaired tumor growth in head neck squamous cell carcinoma.Road to stemness in hepatocellular carcinoma.Endothelial-derived interleukin-6 induces cancer stem cell motility by generating a chemotactic gradient towards blood vessels.Stemness-Related Markers in Cancer.Stage-dependent therapeutic efficacy in PI3K/mTOR-driven squamous cell carcinoma of the skin.Oral Cancer Stem Cells Microenvironment.A mathematical model for IL-6-mediated, stem cell driven tumor growth and targeted treatment.Eugenol potentiates cisplatin anti-cancer activity through inhibition of ALDH-positive breast cancer stem cells and the NF-κB signaling pathway.

P2860

Q26740207-D4D3E4A7-4C3A-4AA7-8B50-FC7966A56090 Q26777882-2F42B561-BB20-4F71-AE8B-7511A651F5CE Q26825164-2E624892-E7F7-490D-A4FB-ECDDC0B4F26D Q33591405-42E9A88B-8A11-4502-B8D1-61D1F4492437 Q33793000-236C4BF7-5FE6-47F0-AA03-61FF8D529E4E Q34334424-279D0FA8-212E-4B58-8735-A9532BCEEE9D Q34368669-CE520798-DF9A-4B71-B7FE-D42253DD4EBB Q34695105-644B3573-A64D-49C8-BE5D-F0E42C05A0F9 Q36116632-9A3A340A-AA59-4A8C-9F4A-E84DDEF7D0D2 Q36356086-C7B23ABA-9413-4CDE-A17E-813DB56B683D Q36544739-655A121E-8757-4B93-9031-D56AFC6F41EA Q36548645-858D1484-B973-4220-8F3B-CF980C446E8D Q36561640-983E8B38-882B-4BEB-A05C-B18EB2962E3F Q36658938-6FCA3190-C7E7-4D8A-9FE4-50592CD731F7 Q36830276-098087D2-4974-4BE1-AB10-8F7C957D6C6F Q37400105-D4DF3441-B755-4056-B345-45D2DFE7CE00 Q38271597-EFE86E1D-4196-4E9F-839B-3DC8FAC43A6F Q38474990-27D18F72-6EE4-4AEA-8316-F19577D4C82E Q38821367-14F99642-4AC7-4A93-A109-07A4AB7A0D89 Q38827211-964A3590-AAF8-41C8-9122-7D075F4FB947 Q38866185-0064A9C1-FE5A-43ED-A53C-2D46D998AD48 Q39224958-345A8B28-BBD0-4854-830F-002F6D83BC5C Q39381795-5905B704-D81E-4B40-BFA4-AE2C0D372B63 Q39394303-709FE88D-CEA2-4B91-9B74-935CEE467372 Q39433158-B6972DEA-C4DE-425D-85B3-6C50D6C6C057 Q39464301-D3ACF338-B92F-435D-8891-809F448562C4 Q39727803-FA017314-3F1A-4436-AFD6-16CDAE5A4A90 Q41346071-813705F6-699C-4288-BDEE-DF5D550B934F Q41956794-54405AFE-9A57-41A1-A947-F3BC0CFD1967 Q42700773-6CFB00CB-AA60-43F0-ABAB-04E3D0E21BDF Q42838383-7C680EBF-9D82-4FE1-9147-0F7E1DC965B4 Q46420352-E94E1BAC-B7AF-469A-92FC-479EED9D16B1 Q47102136-1C1728FF-FD64-4BF6-8568-E2D238625DF6 Q47137381-4B46313A-EAAF-4D45-A78F-26FF1AB40C3C Q47148800-210F5D7A-59DC-49BF-A338-A51B9B28BF44 Q47176774-E898A8EE-D4AC-41D1-B660-4D74F6D63CF8 Q47314965-4E4A78CA-B451-4373-ACA0-48AFB261AAAF Q47330933-01169B0A-3C81-4833-BC49-59766A2D4054 Q47557037-84CF825F-58EB-4778-BCDF-A83A28BBCD83 Q48121718-9E36B13C-EBDD-469B-BEE4-2A74FD1C5B0D

P2860

Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer.

http://www.wikidata.org/entity/Q37689601

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer.

@en

Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer.

@nl

type

label

Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer.

@en

Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer.

@nl

prefLabel

Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer.

@en

Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer.

@nl

P1433

Q37689601-E641BBC2-E7F4-4375-8A6A-D05F1AC38AF7

P1476

Q37689601-4D649EDD-EAFB-4BA0-935F-43513CE64C70

P2093

Q37689601-15C17AB8-F8AF-4516-BBE1-8890BF756514

Q37689601-20CF73D7-02ED-408F-AF05-C567F577D28D

Q37689601-493107E7-EA37-4582-B78F-BFBC15468381

Q37689601-4E3B5FA5-35E2-4289-B33A-E2F9D289CC61

Q37689601-551D69AA-29A3-4723-966A-0352527B8F3C

Q37689601-85FA5B47-5303-44F7-AA8C-007731619325

Q37689601-E77261D9-5886-436B-9CF5-F0D88EC00979

P2860

Q37689601-031E3415-2922-42E1-93AA-360102B04407

Q37689601-04CF13CB-5ED8-4F82-B25D-4593B1539A0B

Q37689601-04D5D33B-8A3D-421E-9C72-98B36BCB5BC4

Q37689601-06634659-183A-4FC1-86A4-D26CE5BAC98A

Q37689601-14EAA2C7-7676-4097-961A-9BD351B98E27

Q37689601-1613D13E-A403-45D8-8468-8AD3BB65ADDD

Q37689601-1A66ED22-7B21-4FA5-B074-5D7F894ED9AD

Q37689601-1E6AAB70-FD30-4423-81B6-060621C747EA

Q37689601-20F4D8A8-2DFF-4DD6-967C-3FB6BC92EBDC

Q37689601-21C6037F-A60E-45C5-B5B7-D2D8CF77A3E9

P304

Q37689601-3ABE4D08-0B87-4F1D-930A-14FCD11F140D

P31

Q37689601-B6494D0D-AB8F-44F7-AB8B-58446E4DCB6E

P356

Q37689601-79B2FD06-DCA9-4380-8F36-A5034F6D4E4A

P433

Q37689601-4B59086A-307A-4C22-8E65-82DFF4D98FE1

P478

Q37689601-A570098A-499D-4249-A889-7829661EF6A9

P50

Q37689601-61F9EFEF-985B-4F99-8DA0-CFD450B6BAE5

P577

Q37689601-BE7D126C-95FC-49E5-9876-C6811CA29E4C

P5875

Q37689601-9D829494-AE99-4394-9ECB-0209421895AA

P698

Q37689601-D14C0463-4718-4BE9-BC12-C50422063DD2

P932

Q37689601-A181A940-6901-462A-ACD6-CF8DDC84F07C

P356

P1433

P1476

Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer

@en

P2093

Carolina Nör

http://www.w3.org/2001/XMLSchema#string

Fernanda Visioli

http://www.w3.org/2001/XMLSchema#string

Jacques E Nör

http://www.w3.org/2001/XMLSchema#string

Joseph I Helman

http://www.w3.org/2001/XMLSchema#string

Kristy A Warner

http://www.w3.org/2001/XMLSchema#string

Lisiane Bernardi

http://www.w3.org/2001/XMLSchema#string

Zhaocheng Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland

Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas

Prospective identification of tumorigenic breast cancer cells

Stem cells, cancer, and cancer stem cells

Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells

The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

Cancer stem cells: mirage or reality?

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

P304

137-146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1593/NEO.131744

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261443358

http://www.w3.org/2001/XMLSchema#string

P698

24709421

http://www.w3.org/2001/XMLSchema#string

P932

3978394

http://www.w3.org/2001/XMLSchema#string